OptimizeRx OPRX Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's accounts receivable, credit loss expense (reversal)?
- OptimizeRx (OPRX) reported accounts receivable, credit loss expense (reversal) of $0 in Q1 2026.
- What is the long-term trend for OptimizeRx's accounts receivable, credit loss expense (reversal)?
- Over 4 years (2021 to 2025), OptimizeRx's accounts receivable, credit loss expense (reversal) has grown at a -100.0% compound annual growth rate (CAGR), from $80K to $0.